vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and PROCORE TECHNOLOGIES, INC. (PCOR). Click either name above to swap in a different company.
PROCORE TECHNOLOGIES, INC. is the larger business by last-quarter revenue ($349.1M vs $205.4M, roughly 1.7× COLLEGIUM PHARMACEUTICAL, INC). COLLEGIUM PHARMACEUTICAL, INC runs the higher net margin — 8.3% vs -10.8%, a 19.0% gap on every dollar of revenue. On growth, PROCORE TECHNOLOGIES, INC. posted the faster year-over-year revenue change (15.6% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $109.2M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 13.8%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Procore Technologies is an American construction management software as a service company founded in 2002, with headquarters in Carpinteria, California. Procore hosts a platform to connect those involved in the construction industry on a global platform. The software allows for the creation of simplified workflows and displays a consolidated view of construction products that includes the tracking of tasks, management of project workflows, and scheduling.
COLL vs PCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $349.1M |
| Net Profit | $17.0M | $-37.6M |
| Gross Margin | 62.5% | 80.1% |
| Operating Margin | 29.6% | -12.3% |
| Net Margin | 8.3% | -10.8% |
| Revenue YoY | 12.9% | 15.6% |
| Net Profit YoY | 35.3% | 39.6% |
| EPS (diluted) | $0.48 | $-0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $349.1M | ||
| Q3 25 | $209.4M | $338.9M | ||
| Q2 25 | $188.0M | $323.9M | ||
| Q1 25 | $177.8M | $310.6M | ||
| Q4 24 | $181.9M | $302.0M | ||
| Q3 24 | $159.3M | $295.9M | ||
| Q2 24 | $145.3M | $284.3M | ||
| Q1 24 | $144.9M | $269.4M |
| Q4 25 | $17.0M | $-37.6M | ||
| Q3 25 | $31.5M | $-9.1M | ||
| Q2 25 | $12.0M | $-21.1M | ||
| Q1 25 | $2.4M | $-33.0M | ||
| Q4 24 | $12.5M | $-62.3M | ||
| Q3 24 | $9.3M | $-26.4M | ||
| Q2 24 | $19.6M | $-6.3M | ||
| Q1 24 | $27.7M | $-11.0M |
| Q4 25 | 62.5% | 80.1% | ||
| Q3 25 | 61.7% | 79.7% | ||
| Q2 25 | 57.7% | 79.1% | ||
| Q1 25 | 54.8% | 79.1% | ||
| Q4 24 | 54.0% | 81.2% | ||
| Q3 24 | 60.8% | 81.4% | ||
| Q2 24 | 62.5% | 83.1% | ||
| Q1 24 | 63.1% | 83.0% |
| Q4 25 | 29.6% | -12.3% | ||
| Q3 25 | 29.7% | -4.4% | ||
| Q2 25 | 18.7% | -9.3% | ||
| Q1 25 | 12.2% | -11.7% | ||
| Q4 24 | 20.9% | -21.9% | ||
| Q3 24 | 21.9% | -12.3% | ||
| Q2 24 | 32.7% | -5.2% | ||
| Q1 24 | 34.1% | -7.0% |
| Q4 25 | 8.3% | -10.8% | ||
| Q3 25 | 15.0% | -2.7% | ||
| Q2 25 | 6.4% | -6.5% | ||
| Q1 25 | 1.4% | -10.6% | ||
| Q4 24 | 6.9% | -20.6% | ||
| Q3 24 | 5.9% | -8.9% | ||
| Q2 24 | 13.5% | -2.2% | ||
| Q1 24 | 19.1% | -4.1% |
| Q4 25 | $0.48 | $-0.25 | ||
| Q3 25 | $0.84 | $-0.06 | ||
| Q2 25 | $0.34 | $-0.14 | ||
| Q1 25 | $0.07 | $-0.22 | ||
| Q4 24 | $0.36 | $-0.42 | ||
| Q3 24 | $0.27 | $-0.18 | ||
| Q2 24 | $0.52 | $-0.04 | ||
| Q1 24 | $0.71 | $-0.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $768.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.3B |
| Total Assets | $1.7B | $2.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $768.5M | ||
| Q3 25 | $285.9M | $684.0M | ||
| Q2 25 | $222.2M | $620.9M | ||
| Q1 25 | $197.8M | $566.7M | ||
| Q4 24 | $162.8M | $775.4M | ||
| Q3 24 | $120.0M | $756.9M | ||
| Q2 24 | $271.6M | $735.4M | ||
| Q1 24 | $318.0M | $744.6M |
| Q4 25 | $301.7M | $1.3B | ||
| Q3 25 | $274.8M | $1.2B | ||
| Q2 25 | $232.2M | $1.2B | ||
| Q1 25 | $234.4M | $1.2B | ||
| Q4 24 | $228.8M | $1.3B | ||
| Q3 24 | $234.3M | $1.3B | ||
| Q2 24 | $216.6M | $1.3B | ||
| Q1 24 | $222.2M | $1.2B |
| Q4 25 | $1.7B | $2.2B | ||
| Q3 25 | $1.6B | $2.1B | ||
| Q2 25 | $1.6B | $2.0B | ||
| Q1 25 | $1.6B | $1.9B | ||
| Q4 24 | $1.7B | $2.1B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.1B | $2.0B | ||
| Q1 24 | $1.1B | $1.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $114.9M |
| Free Cash FlowOCF − Capex | $122.4M | $109.2M |
| FCF MarginFCF / Revenue | 59.6% | 31.3% |
| Capex IntensityCapex / Revenue | 0.3% | 1.6% |
| Cash ConversionOCF / Net Profit | 7.25× | — |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $282.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $114.9M | ||
| Q3 25 | $78.4M | $88.5M | ||
| Q2 25 | $72.4M | $30.8M | ||
| Q1 25 | $55.4M | $66.0M | ||
| Q4 24 | $84.6M | $29.1M | ||
| Q3 24 | $-9.0M | $39.3M | ||
| Q2 24 | $67.4M | $58.7M | ||
| Q1 24 | $61.9M | $69.1M |
| Q4 25 | $122.4M | $109.2M | ||
| Q3 25 | $78.3M | $83.1M | ||
| Q2 25 | $72.4M | $27.9M | ||
| Q1 25 | $54.6M | $62.0M | ||
| Q4 24 | $84.1M | $17.4M | ||
| Q3 24 | $-9.2M | $35.7M | ||
| Q2 24 | $67.1M | $56.8M | ||
| Q1 24 | $61.4M | $67.1M |
| Q4 25 | 59.6% | 31.3% | ||
| Q3 25 | 37.4% | 24.5% | ||
| Q2 25 | 38.5% | 8.6% | ||
| Q1 25 | 30.7% | 20.0% | ||
| Q4 24 | 46.2% | 5.8% | ||
| Q3 24 | -5.8% | 12.1% | ||
| Q2 24 | 46.2% | 20.0% | ||
| Q1 24 | 42.3% | 24.9% |
| Q4 25 | 0.3% | 1.6% | ||
| Q3 25 | 0.1% | 1.6% | ||
| Q2 25 | 0.0% | 0.9% | ||
| Q1 25 | 0.4% | 1.3% | ||
| Q4 24 | 0.3% | 3.9% | ||
| Q3 24 | 0.2% | 1.2% | ||
| Q2 24 | 0.2% | 0.7% | ||
| Q1 24 | 0.4% | 0.8% |
| Q4 25 | 7.25× | — | ||
| Q3 25 | 2.49× | — | ||
| Q2 25 | 6.05× | — | ||
| Q1 25 | 22.92× | — | ||
| Q4 24 | 6.75× | — | ||
| Q3 24 | -0.96× | — | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
COLL
Segment breakdown not available.
PCOR
| US | $298.3M | 85% |
| Non Us | $50.9M | 15% |
